Pentoxyverine-d8 structure
|
Common Name | Pentoxyverine-d8 | ||
---|---|---|---|---|
CAS Number | 1329797-10-5 | Molecular Weight | 341.51 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H23D8NO3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Pentoxyverine-d8Pentoxyverine-d8 (Carbetapentane-d8) is the deuterium labeled Pentoxyverine. Pentoxyverine (Carbetapentane) is a sigma-1 receptor agonist, with a Ki of 75 nM on guinea-pig brain membranes. Pentoxyverine is a centrally-acting cough suppressant with antimuscarinic and anticonvulsant properties. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4]. |
Name | Pentoxyverine-d8 |
---|
Description | Pentoxyverine-d8 (Carbetapentane-d8) is the deuterium labeled Pentoxyverine. Pentoxyverine (Carbetapentane) is a sigma-1 receptor agonist, with a Ki of 75 nM on guinea-pig brain membranes. Pentoxyverine is a centrally-acting cough suppressant with antimuscarinic and anticonvulsant properties. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C20H23D8NO3 |
---|---|
Molecular Weight | 341.51 |
Hazard Codes | Xi |
---|